Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 86 | 3 | ADIPONECTIN//PEROXISOME//ENDOCRINOLOGY & METABOLISM | 81747 |
| 1307 | 2 | THIAZOLIDINEDIONES//PPAR GAMMA//PIOGLITAZONE | 8873 |
| 14887 | 1 | PPAR BETA DELTA//PPAR DELTA//PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA | 770 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | PPAR BETA DELTA | authKW | 1164258 | 6% | 66% | 43 |
| 2 | PPAR DELTA | authKW | 1073951 | 9% | 40% | 66 |
| 3 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA | authKW | 1026872 | 5% | 61% | 41 |
| 4 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BETA DELTA | authKW | 547232 | 2% | 70% | 19 |
| 5 | MOL TOXICOL CARCINOGENESIS | address | 416645 | 7% | 18% | 56 |
| 6 | GW0742 | authKW | 314838 | 1% | 77% | 10 |
| 7 | GW501516 | authKW | 266029 | 2% | 50% | 13 |
| 8 | PPAR BETA | authKW | 216144 | 2% | 41% | 13 |
| 9 | PPARD | authKW | 198087 | 1% | 44% | 11 |
| 10 | FRONTIERS GENET | address | 183922 | 3% | 22% | 20 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Dermatology | 891 | 9% | 0% | 66 |
| 2 | Cell Biology | 731 | 17% | 0% | 133 |
| 3 | Biochemistry & Molecular Biology | 654 | 27% | 0% | 208 |
| 4 | Endocrinology & Metabolism | 653 | 12% | 0% | 94 |
| 5 | Medicine, Research & Experimental | 452 | 10% | 0% | 78 |
| 6 | Peripheral Vascular Diseases | 317 | 7% | 0% | 51 |
| 7 | Pharmacology & Pharmacy | 178 | 11% | 0% | 87 |
| 8 | Oncology | 157 | 9% | 0% | 73 |
| 9 | Cardiac & Cardiovascular System | 75 | 5% | 0% | 40 |
| 10 | Biophysics | 60 | 4% | 0% | 33 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MOL TOXICOL CARCINOGENESIS | 416645 | 7% | 18% | 56 |
| 2 | FRONTIERS GENET | 183922 | 3% | 22% | 20 |
| 3 | PROGRAM BIOCHEM MICROBIOL MOL BIOL | 125745 | 2% | 24% | 13 |
| 4 | MOL BIOL TUMOR IMT | 119240 | 2% | 22% | 13 |
| 5 | PROGRAM MOL TOXICOL | 93550 | 1% | 57% | 4 |
| 6 | BIOL TISSU ADIPEUX | 81859 | 0% | 100% | 2 |
| 7 | INTEGRAT GENOM | 79955 | 6% | 4% | 46 |
| 8 | PHARMACOL THER EUT CHEM | 61684 | 2% | 11% | 14 |
| 9 | TUMOR BIOL IMMUNOL ZTI | 61391 | 0% | 50% | 3 |
| 10 | CARDIOVASC UROL EXCELLENCE DRUG DISCOVERY | 54571 | 0% | 67% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PPAR RESEARCH | 89083 | 4% | 7% | 33 |
| 2 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2969 | 4% | 0% | 28 |
| 3 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1783 | 1% | 0% | 11 |
| 4 | EXPERIMENTAL DERMATOLOGY | 1206 | 1% | 0% | 9 |
| 5 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 887 | 2% | 0% | 13 |
| 6 | CURRENT OPINION IN LIPIDOLOGY | 738 | 1% | 0% | 5 |
| 7 | CURRENT OPINION IN INVESTIGATIONAL DRUGS | 622 | 0% | 1% | 3 |
| 8 | AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 464 | 0% | 0% | 3 |
| 9 | EXPERT OPINION ON THERAPEUTIC TARGETS | 452 | 1% | 0% | 4 |
| 10 | DIABETES | 388 | 1% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |